ABsTRAcCT Thrombotic obstruction is the most feared complication of the Bjork-Shiley tilting disc prosthesis. From 1971 to 1982 1186 Bjork-Shiley valves were implanted in 900 patients. There were 93 deaths in hospital. Eight hundred and seven patients have been followed for a total of 4146 patient years; 14 patients were lost to follow up. Nineteen cases of thrombotic obstruction were identified at necropsy or at a repeat operation in the study group. The mitral prosthesis was thrombosed in 16 patients, the aortic in two, and the tricuspid in one. The incidence for this complication has been calculated to be 0-46 per 100 patient years for all valve positions, 0-79 for single mitral valve replacements, 0-18 for aortic replacements, and 0 63/100 for the tricuspid position. The maximum possible incidence of this complication in this population has been calculated to be 1-4 per 100 patient years. The mortality rate was 41-7% for reoperation and 63% for the development of the complication. Risk factors that have been identified are inadequate anticoagulant control, poor preoperative exercise capacity, and possibly also the implantation of small prostheses.
The Bjork-Shiley tilting disc prosthesis is an extensively used mechanical valve of proved long term functional durability.' It is, however, vulnerable to rapidly progressive malfunction if thrombus forms on the valve and restricts the movement of the disc. The incidence of this complication has been reported in several series.'-'5 The figures are generally based on those patients who presented to hospital or who were operated on for the complication and may therefore represent only the "tip of the iceberg' of the true incidence of thombus formation. '5 We are fortunate in the West of Scotland in that demography and the centralisation of the cardiac surgical service enable us to follow our patients relatively closely. Follow up data have been analysed and we have used them, firstly, to estimate a possible range for the incidence of this complication within the population and, secondly, to elucidate the aetiology of the condition.
Patients and methods
In Glasgow during the years 1971-82, 1186 BjorkShiley valves were implanted in the 900 patients comprising this series. After operation a standard postoperative management and follow up regimen were used for all patients. Anticoagulant control (maintaining the thrombotest response at 5-10%) was achieved by the use of warfarin, which was started after the removal of the pericardial and mediastinal drains. In most cases this was by the evening of the first postoperative day. Heparin was not used routinely in the postoperative period. Anticoagulant control was achieved thereafter by regular attendance at an outpatient clinic. The patients also attended an outpatient clinic six weeks after operation for examination by a member of the surgical staff. They were then reviewed by medical and surgical cardiologists at least annually. Review data are stored on floppy discs and were available for microprocessor analysis. Details of the study group Six of the patients had a history of poor anticoagulant control requiring hospital admission for supervised management. Four of these had previously undergone psychiatric treatment for depression. In eight patients, however, anticoagulant control appeared to be satisfactory on the basis of their anticoagulant records and the results of the thrombotests performed on admission. Details of anticoagulant control were not available for five patients, but they had been taking their warfarin regularly.
Eighteen of the patients had a history of rheumatic fever; one patient had congenital aortic stenosis and two patients had had ischaemic heart disease requiring coronary artery surgery. 16 We considered several possible aetiological factors and compared their incidence in the group with thrombosed group valves and in the total group of patients who were followed up.
Possible causal factors Age
The mean age at operation of the group with thrombosed valves was 46 years, compared with 48 years for the whole series.
Sex
The male to female ratio in the thrombosed group was 1:18 and in the whole series was 1:1 9. This difference is significant at the 1% level. Seventy four per cent of the valves, however, became thrombosed after single mitral valve replacements, a group in which the female to male ratio is 3:1. When this is taken into account the sex ratio in the thrombosed group is not significantly different from that in the whole series.
Preoperative exercise tolerance 95% of the patients with thrombosed prostheses were in New York Heart Association grades III or IV before operation while only 69% of the patients in the whole series were similarly distributed. This difference is significant at the 2% level. Table 3 shows the distribution of thrombotic obstructions in the mitral and tricuspid positions. Despite the apparent relationship between small prostheses and thrombotic obstruction, the relatively small numbers make this inference statistically invalid.
Cardiac rhythm
Perhaps surprisingly, four of the patients with thrombosed prostheses were in sinus rhythm at the time of presentation. These were both the patients with aortic prostheses and two of the patients with mitral prostheses. The other patients were in atrial fibrillation, but clotting of the atrium was not found in association with the thrombosed prosthesis in this group. (fig 3) . The macroscopic appearance of the thrombus was often described as laminar, which implies a chronic process of thrombus deposition, until movement of the disc occluder is eventually acutely prevented. Wright et al'5 contend that minor thrombosis leading to pannus formation may produce small limitations of disc motion before thrombosis of the valve. This view would be supported by the fact that in our series the duration of symptoms Ryder, Bradley, Brannan, Turner, Bain ranged from 24 hours to 10 weeks. The initial symptoms were often described by our patients as resembling a "flu like" illness. Possibly a subclinical form of endocarditis may be an initiating factor in the formation of thrombus on the valve and sewing ring. We could find no firm evidence, however, to support this idea from studies of white cell counts, blood cultures, body temperatures, and erythrocyte sedimentation rates at the time of presentation with thrombotic obstruction. We consider it more likely that the illness caused the patient to stay in bed, thereby reducing transvalvar flow, and predisposing towards thrombus build up. In support of this hypothesis, we have noted a correlation between poor exercise tolerance and incidence of thrombotic obstruction (see below). Annular calcification was thought by our group to provide a possible nidus for the formation of thrombus, but our figures do not support this hypothesis.
Severely impaired exercise tolerance appears to be a significant predisposing factor. Many of these patients have impaired myocardial contractility secondary to rheumatic carditis and as a result have chronically low cardiac outputs. The resulting low transvalvar flow predisposes to platelet aggregation.
Despite the apparent relationship between small prostheses and thrombotic obstruction, the relatively small numbers make the association nonsignificant. Interestingly, however, the incidence of thrombosis in the 29, 31, and 33 mm sizes are very similar-2-3%, 2*4%, and 2.5%. The orifices of these valves are in fact identical, and the alteration in implantation size is brought about by changes in the dimensions of the sewing ring.
Bjork and Henze' showed that the incidence of thrombosis of aortic prosthetic valves was 8 The incidence for this complication in our series was 0O46% patient years for all prostheses (0-18% patient years for the aortic replacements and 0 79% patient years for mitral valve replacements), which compares very favourably with the results in other published series.5 8 '5 To quote Albert Starr in a recent manuscript reviewer's comment, "The patients presented in this review all lived long enough to undergo reoperation. These patients represent only the tip of the iceberg with regard to the natural history of this complication, since 'approximately 50% of the patients in whom thrombosis of the tilting disc valve has been reported have died rapidly in the hospital before reoperation'72 A further percentage of patients, possibly a significant number, die even prior to hospitalisation." We have identified those patients dying in hospital without operation. With regard to those patients dying before hospital admission, we have analysed the records of all the patients who died after leaving hospital to determine the cause of their death. If this could not be determined, in the absence of necropsy or detailed clinical information, then these patients were regarded as having died from thrombotic valvular obstruction. Using these criteria and including patients lost to follow up, we have calculated a figure of 1-4 per 100 patient years as the maximum possible incidence of this complication in our population (table 4).
All the valves which thrombosed in this series were of the original spherical flat disc design. The series includes 151 patients, in whom altogether 184 concavo-convex modified Bjork-Shiley valves were implanted. These patients have been followed for a total of 452 patient years, up to the end of 1983. So far, we have not identified a case of thrombotic obstruction in this group. Figure 3 is an actuarial survival curve of all patients in the series.
In summary, thrombotic obstruction of the Bjork-Shiley valve is a serious complication with a uniformly fatal outcome unless promptly diagnosed and replaced at an emergency repeat operation. Risk factors which we have identified are inadequate anticoagulation control, poor preoperative exercise capacity, and possibly also the use of small prostheses.
